A presentation and companion FAQ provide clarification and information about the new SAMHSA guidance for the revised SAMHSA 42 CFR Part 2 Rule. Released in July 2020, the revised rule was designed to improved coordination of care for patients in treatment for substance use disorder (SUD) while protecting their confidentiality against unauthorized disclosure and use of patient health information (PHI). Prepared by the Center of Excellence for Protected Health Information as well as the University of New Hampshire Institute for Health Policy and Practice, answers are provided for common questions that arose during the HITEQ Center’s webinar on Jan. 19, 2021, including clarification on health center specific questions regarding patient consent, telehealth, SUD and medication-assisted treatment (MAT). Access the slides, transcript and FAQs. HITEQ is a HRSA National Training & Technical Assistance Partner, under contract to the Bureau of Primary Health Care to support health centers in full optimization of their IT systems.
